FDA sets July decision date for full approval of Leqembi
FDA widens Lilly's Verzenio breast cancer reach
Praxis shares fall 48% following mixed data for essential tremor candidate
ACC 2023 – Esperion’s outcomes win looks lackluster
*please scroll down for all the latest news*
